Imperial College London Featured PhD Programmes
King’s College London Featured PhD Programmes
University of Reading Featured PhD Programmes
"metastasis"×
10 miles

metastasis PhD Projects, Programs & Scholarships

We have 54 metastasis PhD Projects, Programs & Scholarships

  • "metastasis" ×
  • clear all
Order by 
Showing 1 to 15 of 54
  RET a novel therapeutic target to treat breast cancer brain metastasis
  Prof L Young, Dr A Hill
Applications accepted all year round

Funding Type

PhD Type

Metastatic disease recurrence occurs in up to 30% of breast cancer patients with approximately 20% of these tumours metastasising to the brain.
  Does fatty acid uptake by oral cancer cells drive metastasis?
  Dr C Murdoch, Dr H Colley
Applications accepted all year round

Funding Type

PhD Type

The cell surface receptor CD36 belongs to a large scavenger receptor family that primarily bind lipid-containing molecules. Until recently their expression was thought to be restricted to macrophages and endothelial cells but recent data suggest that epithelial cancer cells may also express this receptor.
  Testing the function of immune suppressive cytokines and cells in bone metastasis
  Assoc Prof B Parker
Applications accepted all year round

Funding Type

PhD Type

Bone metastasis is a common occurrence in breast and prostate cancer that leads to patient morbidity and, in many cases, mortality.
  Cell biology and evolution of cancer metastasis
  Prof P R Dash
Applications accepted all year round

Funding Type

PhD Type

We are interested in the spread of cancer, a process called metastasis. Metastasis is responsible for the majority of cancer deaths and there are currently no effective treatments to stop this process.
  Targeting IL-1B to improve outcome for patients with breast cancer bone metastases.
  Dr P Ottewell
Application Deadline: 30 July 2020

Funding Type

PhD Type

Background. Breast cancer metastasis to bone is currently incurable. Treatment consists of combining anti-tumour therapies with bone strengthening agents such as zoledronic acid (ZA).
  Gene regulation in cancer metastasis
  Dr F Wardle
Applications accepted all year round

Funding Type

PhD Type

A PhD studentship is available to work in the laboratory of Dr. Fiona Wardle (www.kcl.ac.uk/research/profile/wardle-group) in the Randall Centre for Cell and Molecular Biophysics, King’s College London.
  A key role for FKBPL in the regulation of cancer stem cell signalling and the microenvironment; therapeutic implications for tumour growth and metastasis
  Prof T Robson, Prof D O'Connor
Applications accepted all year round

Funding Type

PhD Type

Cancer stem cells (CSCs) are a special type of cell found within tumours that are able to undergo unlimited self-renewal and are highly resistant to therapy.
  Investigating the role of the protease ADAMTS5 in ovarian cancer
  Dr E Rainero
Applications accepted all year round

Funding Type

PhD Type

Ovarian cancer is the most lethal gynaecological malignancy. Mostly because of late stage diagnosis, the 5-year survival rate is.
  Watching cancer metastasise live and investigating the underlying mechanisms
  Dr K Campbell, Dr M J P Simons
Applications accepted all year round

Funding Type

PhD Type

Cancer metastasis accounts for around 90% of cancer deaths. While the survival rate has been improved over the years through early diagnosis, limited progress has been made in the targeting of metastasis.
  Differential Regulation of mRNA isoform Expression in Metastatic Cancer
  Dr W English, Dr M Dunning
Applications accepted all year round

Funding Type

PhD Type

Metastasis is the principle cause of mortality in patients with cancer. An increased understanding of the molecular drivers that lead to primary, localised cancer becoming metastatic disease could provide new opportunities for therapy.
  Mechanisms of Cancer Stem Cell Survival, Metastasis Formation and Immune Evasion in Cancer
  Dr D Widera
Applications accepted all year round

Funding Type

PhD Type

Recent research suggests that cancer cells within a tumour represent a highly heterogeneous cell population. In particular many tumours contain small percentage of cells that share several characteristics with stem cells.
  Combined targeting of PD-L1 and NFκB pathways to reverse T-cell exhaustion and restore anti-tumour immunity in breast cancer.
  Dr A Idris
Application Deadline: 1 July 2020

Funding Type

PhD Type

The majority of deaths from breast cancer following conventional therapies are a result of metastases. Programmed death 1 ligand (PD-L1), a negative regulator of the immune system, is highly expressed in triple negative breast tumours and cell lines, and its expression is associated with suppressed anti-tumour immunity.
  Evaluation of natural and novel tumour-selective cannabinoids in melanoma progression and metastases
  Dr A Idris, Dr S Danson
Application Deadline: 1 July 2020

Funding Type

PhD Type

The majority of deaths from melanoma following conventional therapies are a result of metastases.
  Investigating anti-metastatic drugs in human melanoma cells
  Dr S Vass, Prof M Rae
Application Deadline: 31 May 2020

Funding Type

PhD Type

Metastasis is the term used to describe the movement of cancer cells from the primary site of disease to other areas of the body.
  Breast Cancer Omics and Modelling
  Dr C Francavilla, Prof R Breitling
Applications accepted all year round

Funding Type

PhD Type

Background and goals. Breast cancer is the major cause of death among women and 90% of deaths are caused by incurable metastasis.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.